Cook DJ, Simel DL The Rational Clinical Examination. Does this patient have abnormal central venous pressure? JAMA. 1996 Feb 28;275(8):630-4.
Cui H, He G, Yang S, Lv Y, Jiang Z, Gang X, Wang G Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Patients. Front Neurosci. 2019 Nov 8;13:1170. doi: 10.3389/fnins.2019.01170. eCollection 2019. Review.
Imbriano LJ, Mattana J, Drakakis J, Maesaka JK Identifying Different Causes of Hyponatremia With Fractional Excretion of Uric Acid. Am J Med Sci. 2016 Oct;352(4):385-390. doi: 10.1016/j.amjms.2016.05.035. Epub 2016 Jul 6.
Musch W, Decaux G Treating the syndrome of inappropriate ADH secretion with isotonic saline. QJM. 1998 Nov;91(11):749-53.
Musch W, Decaux G Utility and limitations of biochemical parameters in the evaluation of hyponatremia in the elderly. Int Urol Nephrol. 2001;32(3):475-93.
Nik Muhamad NA, Safferi RS, Robertson CE Internal Jugular Vein Height and Inferior Vena Cava Diameter Measurement using Ultrasound to Determine Central Venous Pressure: A Correlation Study. Med J Malaysia. 2015 Apr;70(2):63-6.
Oh JY, Shin JI Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences. Front Pediatr. 2015 Jan 22;2:146. doi: 10.3389/fped.2014.00146. eCollection 2014. Review.
Rizkallah J, Jack M, Saeed M, Shafer LA, Vo M, Tam J Non-invasive bedside assessment of central venous pressure: scanning into the future. PLoS One. 2014 Oct 3;9(10):e109215. doi: 10.1371/journal.pone.0109215. eCollection 2014.
Soni SS, Adikey GK, Raman AS Fractional excretion of uric acid as a therapeutic monitor in cerebral salt wasting syndrome. Saudi J Kidney Dis Transpl. 2008 Jan;19(1):106-8.
Tzoulis P, Runkle-De la Vega I The Diagnostic Approach to the Patient with Hyponatremia: Are the Correct Investigations Being Done? Front Horm Res. 2019;52:190-199. doi: 10.1159/000493248. Epub 2019 Jan 15. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
